Agrylin User Reviews
Patient Discussions are not a substitute for professional medical advice, diagnosis, or treatment. Never delay or disregard seeking professional medical advice from your physician or other qualified health provider because of something you have read on MedicineNet. The opinions expressed in the comments section are of the author and the author alone. MedicineNet does not endorse any specific product, service or treatment.
If you think you have a medical emergency, call your doctor or 911 immediately.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
This medication reduced the platlet count, and was easy to swallow. However, everything I have read and the experience of my husband taking this drug, I am surprised it's still on the market. My husband had a massive stroke. When life flighted to UC Davis the Hem. doctor told me he should have never been placed on this drug. It was probably the cause of his bleed. When I looked it up on the internet, it showed that during an Agrylin study of 89 people, 57% of the people dropped out due to serious complications. This was on WebMd dated July 5, 2005. In fact, it stated that their findings were so astonishing that they halted their study to publish the results. I continued my search and found that several doctors have found that Agrylin is not a suitable choice for ET. I continue to research it and continue to find more and more. I have contacted the FDA and have received no response other than they would check into it. Published: March 16, 2008 ::